SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Deutsche Bank Cuts Harmony Biosciences Price Target to $38, Keeps Hold Rating

Deutsche Bank lowered its price target from $42 to $38 and maintained its Hold rating on Harmony Biosciences.

HRMY

Related stories